Application of CRISPR/Cas9 Technology in Cancer Treatment: A Future Direction

Authors: Ali A. Rabaan, Hajir AlSaihati, Rehab Bukhamsin, Muhammed A. Bakhrebah, Majed S. Nassar, Abdulmonem A. Alsaleh, Yousef N. Alhashem, Ammar Y. Bukhamseen, Khalil Al-Ruhimy, Mohammed Alotaibi, Roua A. Alsubki, Hejji E. Alahmed, Saleh Al-Abdulhadi, Fatemah A. Alhashem, Ahlam A. Alqatari, Ahmed Alsayyah, Ramadan Abdelmoez Farahat, Rwaa H. Abdulal, Ali H. Al-Ahmed, Mohd. Imran, Ranjan K. Mohapatra

Source: Current Oncology, Vol 30, Iss 2, Pp 1954-1976 (2023)

Subject Terms: CRISPR/Cas, advanced technologies, advanced therapeutics, cancer, cancer treatment, oncoviruses, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://www.mdpi.com/1718-7729/30/2/152; https://doaj.org/toc/1198-0052; https://doaj.org/toc/1718-7729

Access URL: https://doaj.org/article/e7ad0bc73b354ac5865856d562984385